AB
SGMO

Amalgamated Bank’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Amalgamated Bank’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,874
Closed -$3K – 3098
2024
Q1 		$3K Sell
4,874
-7,382
-60% -$5.35K ﹤0.01% 2848
2023
Q4 		$7K Sell
12,256
-1,451
-11% -$669 ﹤0.01% 2914
2023
Q3 		$8K Hold
13,707
– – ﹤0.01% 2935
2023
Q2 		$18K Sell
13,707
-890
-6% -$1.22K ﹤0.01% 2798
2023
Q1 		$26K Sell
14,597
-2,224
-13% -$6.35K ﹤0.01% 2552
2022
Q4 		$53K Buy
16,821
+693
+4% +$2.69K ﹤0.01% 2392
2022
Q3 		$79K Buy
16,128
+839
+5% +$4.31K ﹤0.01% 2260
2022
Q2 		$63K Sell
15,289
-3,518
-19% -$15.2K ﹤0.01% 2368
2022
Q1 		$109K Sell
18,807
-1,577
-8% -$9.38K ﹤0.01% 2163
2021
Q4 		$153K Sell
20,384
-210
-1% -$1.82K ﹤0.01% 2008
2021
Q3 		$186K Sell
20,594
-1,017
-5% -$10.1K ﹤0.01% 2004
2021
Q2 		$259K Buy
21,611
+5,247
+32% +$59.4K ﹤0.01% 1946
2021
Q1 		$205K Sell
16,364
-1,629
-9% -$22K 0.01% 1476
2020
Q4 		$281K Buy
17,993
+88
+0.5% +$1.03K 0.01% 1263
2020
Q3 		$169K Sell
17,905
-452
-2% -$4.89K 0.01% 1338
2020
Q2 		$164K Sell
18,357
-1,318
-7% -$12.2K 0.01% 1331
2020
Q1 		$125K Sell
19,675
-522
-3% -$3.87K ﹤0.01% 1461
2019
Q4 		$169K Buy
20,197
+817
+4% +$7.51K ﹤0.01% 1678
2019
Q3 		$175K Sell
19,380
-126
-0.6% -$1.41K ﹤0.01% 1572
2019
Q2 		$210K Buy
19,506
+3,958
+25% +$42.1K ﹤0.01% 1561
2019
Q1 		$148K Buy
15,548
+549
+4% +$5.61K ﹤0.01% 1562
2018
Q4 		$172K Buy
+14,999
New +$186K ﹤0.01% 1443
2018
Q3 		– Sell
-15,478
Closed -$220K – 1600
2018
Q2 		$220K Buy
15,478
+4,294
+38% +$71.3K 0.01% 1515
2018
Q1 		$212K Sell
11,184
-259
-2% -$5.54K 0.01% 1429
2017
Q4 		$188K Buy
11,443
+893
+8% +$13.3K 0.01% 1513
2017
Q3 		$158K Buy
+10,550
New +$117K ﹤0.01% 1484

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Amalgamated Bank's SGMO Position: Q2 2024 in Review

Amalgamated Bank sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2024, closing a stake of 4,874 shares — an estimated $3K sold.

Amalgamated Bank first reported a position in SGMO in Q3 2017 and held it in 26 quarters. The position peaked at $281K in Q4 2020. 129 funds tracked by Wall St. Rank hold SGMO as of Q2 2024.

  • Amalgamated Bank reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2024 after selling out during the quarter.
  • Amalgamated Bank sold 4,874 SANGAMO THERAPEUTICS INC shares in Q2 2024, an estimated $3K.
  • Amalgamated Bank first reported a position in SANGAMO THERAPEUTICS INC in Q3 2017 and held it in 26 quarters.
  • Amalgamated Bank's SANGAMO THERAPEUTICS INC position peaked at $281K in Q4 2020.
  • 129 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2024.

Based on Amalgamated Bank's 13F filing for Q2 2024, filed 12 Aug 2024.